⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Nuvectis Pharma, Inc. Common Stock

$18.57
+0.26 (+1.42%)

Volume:

98.878K ($1.83M)

Market Capitalization:

$606.20M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Nuvectis Pharma Market Segments

After Hours

+0.00(+0.00%)
Open$18.57
Close$18.57
Low$18.57
Low Change0.00 (0.00%)
High$18.57
High Change+0.00 (+0.00%)
Range$0.00
Volume17.11K
Dollar Volume$317.73K

Regular Trading Hours

-0.08(-0.43%)
Open$18.61
Close$18.53
Low$18.32
Low Change-0.30 (-1.59%)
High$18.97
High Change+0.36 (+1.93%)
Range$0.66
Volume81.768K
Dollar Volume$1.52M

Premarket

*No Trades in Segment

Overnight

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$18.36
Close$18.36
Low$18.10
Low Change-0.26 (-1.43%)
High$18.36
High Change+0.00 (+0.00%)
Range$0.26
Volume17.026K
Dollar Volume$312.60K

Regular Trading Hours Yesterday

-0.12(-0.65%)
Open$18.43
Close$18.31
Low$17.91
Low Change-0.52 (-2.82%)
High$18.83
High Change+0.40 (+2.17%)
Range$0.92
Volume155.925K
Dollar Volume$2.85M

Premarket Yesterday

*No Trades in Segment

Nuvectis Pharma Top Trades

Nuvectis Pharma's top trade so far today returned +1.93%, while the top short trade returned -2.32%.

Nuvectis Pharma Moving Averages

5 Day Moving Average (SMA5)$19.24
10 Day Moving Average (SMA10)$19.40
20 Day Moving Average (SMA20)$19.78
50 Day Moving Average (SMA50)$21.64
100 Day Moving Average (SMA100)$20.05
200 Day Moving Average (SMA200)$14.51

Nuvectis Pharma Statistics

Average Volume (30 Days)195.5K
P/E Ratio (Current)-22.71
EPS (Current)-$0.93
Dividend Yield0.00%
Free Cash Flow-$19.51M
Cash Ratio1.67
Current Ratio1.68
Quick Ratio1.68
Debt to Equity0.00
Enterprise Value$667.28M
EV to EBITDA-23.11
EV to Sales—
Price to Book75.91
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales—
Return on Assets-1.35%
Return on Equity-3.33%

Nuvectis Pharma Stock Splits

There have been no stock splits for Nuvectis Pharma (NVCT).

Nuvectis Pharma Dividends

There have been no dividends for Nuvectis Pharma (NVCT).